SIRT4 and breast carcinoma: To verify that SIRT4 enhances the sensitivity of ER‐positive breast cancer cells to tamoxifen, we transfected ER‐positive MCF7 and T47D breast cancer cells with plasmids containing SIRT4 or empty vectors and measured cell viability by CCK‐8 assay after treatment with different concentrations of tamoxifen.